- Home
- ACIU vs AIRJ Comparison
ACIU vs AIRJ Comparison
Compare ACIU & AIRJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- AIRJ
- Stock Information
- Founded
- ACIU 2003
- AIRJ N/A
- Country
- ACIU Switzerland
- AIRJ United States
- Employees
- ACIU N/A
- AIRJ N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- AIRJ
- Sector
- ACIU Health Care
- AIRJ
- Exchange
- ACIU Nasdaq
- AIRJ NYSE
- Market Cap
- ACIU 332.4M
- AIRJ 285.0M
- IPO Year
- ACIU 2016
- AIRJ N/A
- Fundamental
- Price
- ACIU $3.15
- AIRJ $8.35
- Analyst Decision
- ACIU Strong Buy
- AIRJ
- Analyst Count
- ACIU 2
- AIRJ 0
- Target Price
- ACIU $12.00
- AIRJ N/A
- AVG Volume (30 Days)
- ACIU 153.3K
- AIRJ 38.4K
- Earning Date
- ACIU 11-05-2024
- AIRJ 11-13-2024
- Dividend Yield
- ACIU N/A
- AIRJ N/A
- EPS Growth
- ACIU N/A
- AIRJ N/A
- EPS
- ACIU N/A
- AIRJ 4.07
- Revenue
- ACIU $48,505,404.00
- AIRJ N/A
- Revenue This Year
- ACIU $85.33
- AIRJ N/A
- Revenue Next Year
- ACIU $80.69
- AIRJ N/A
- P/E Ratio
- ACIU N/A
- AIRJ $2.05
- Revenue Growth
- ACIU 4097200.00
- AIRJ N/A
- 52 Week Low
- ACIU $2.25
- AIRJ $4.94
- 52 Week High
- ACIU $5.14
- AIRJ $49.11
- Technical
- Relative Strength Index (RSI)
- ACIU 45.68
- AIRJ 67.79
- Support Level
- ACIU $3.10
- AIRJ $7.77
- Resistance Level
- ACIU $3.25
- AIRJ $8.55
- Average True Range (ATR)
- ACIU 0.14
- AIRJ 0.67
- MACD
- ACIU -0.02
- AIRJ 0.05
- Stochastic Oscillator
- ACIU 13.16
- AIRJ 79.17
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About AIRJ MONTANA TECHNOLOGIES CORP
Montana Technologies Corp is engaged in transformational technology that provides significant energy efficiency gains in air conditioning and comfort cooling applications, as well as a potential source of potable water, all through its proprietary "AirJoule" unit.